Martin H. Huber Jr. - President, CEO, Director at Mersana Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Stock Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Martin H. Huber Jr. - trading volume in the past year for Mersana Therapeutics, Inc.

Holdings reported by Martin H. Huber Jr. for Mersana Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 500K $980K $1.96 Sep 11, 2024 Direct Common Stock
Common Stock 116K $205K $1.76 Sep 12, 2024 Direct
Restricted Stock Unit 44.3K $120K $2.71 Jan 15, 2024 Direct Common Stock
Stock Option (Right to Buy) 199K Jan 15, 2024 Direct Common Stock

Transactions reported by Martin H. Huber Jr. for Mersana Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.